ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Hammer to Produce US-USSR “Cancer Summit” March 29

March 25, 1988

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013